Last reviewed · How we verify
NCT06942364
Action Observation Therapy in Hemiparetic CP: Impact on Balance & Lower Limb Function
NA trial testing Action Observation Therapy in Hemiparetic Cerebral Palsy Children in 20 participants. Completed in 10 December 2024.
10 June 2024
Quick facts
| Lead sponsor | Fatih Tekin |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 10 January 2023 |
| Primary completion | 10 June 2024 |
| Estimated completion | 10 December 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Action Observation Therapy
- conventional physiotherapy
Conditions studied
- Hemiparetic Cerebral Palsy Children — all drugs for Hemiparetic Cerebral Palsy Children →
Sponsor
Fatih Tekin
Who can join
Adults 5 to 12, any sex, with Hemiparetic Cerebral Palsy Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Action Observation Therapy (AOT) leverages the mirror neuron system to enhance motor learning and is anticipated to improve upper extremity function in children with cerebral palsy. However, its effects on balance, lower extremity function, and gait performance in children with hemiparetic cerebral palsy remain underexplored. The planned study aims to evaluate whether the addition of AOT to conventional physiotherapy will positively influence balance, lower extremity function, and gait performance in this population. Objective: The study is designed to assess the efficacy of incorporating AOT as an adjunct to conventional physiotherapy in improving balance, lower extremity function, and gait performance in children with hemiparetic cerebral palsy. Methods: A patient cohort consisting of children with hemiparetic cerebral palsy (GMFCS levels I and II) is planned to be assembled. It is expected that a total of 20 patients will be recruited and then randomly allocated into an experimental group and a control group. The experimental group is scheduled to receive conventional physiotherapy in addition to AOT sessions, while the control group is planned to receive conventional physiotherapy only. The intervention period is planned for 6 weeks, during which both groups will participate in 12 physiotherapy sessions. Additionally, the experimental group is scheduled to undergo AOT sessions twice weekly, with each session lasting 30 minutes. Outcome measures to be employed will include the Timed Up and Go (TUG) test, Pediatric Balance Scale, Five-Step Stair Climbing and Descending Test, and the 6-Minute Walk Test (6MWT). This study is expected to systematically evaluate the potential benefits of adding AOT to standard physiotherapy regimens for enhancing balance, lower extremity function, and gait performance in children with hemiparetic cerebral palsy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06942364
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Action Observation Therapy
Trials testing the same drug.
- NCT07237724 — Effects of Motor Imagery on Pain, Function, Endurance, Kinesiophobia and Sleep Quality in Patients With Non-specific Low · NA · not yet recruiting
- NCT06794749 — Action Observation Therapy in Chronic Stroke · NA · completed
- NCT07418970 — Effects of Action Observation Therapy in Geriatric Individuals · NA · completed
- NCT07078812 — Mirror Therapy and Action Observation Therapy on Upper Limb Sensory Motor Recovery and Quality of Life in Subacute Strok · NA · completed
- NCT06196229 — Effects of Action Observation Therapy Based on Virtual Reality for Upper Extremity Rehabilitation in Stroke · NA · recruiting
Other Fatih Tekin trials
Trials by the same sponsor.
- NCT05788263 — The Effects of Neuroscience-Based Exercise · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06942364 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fatih Tekin
- Last refreshed: 24 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06942364.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing